Difference between revisions of "Category:Anti-SLAMF7 antibodies"
Jump to navigation
Jump to search
(Created page with "Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7). Elotuzumab is the first FDA-...") |
m |
||
| Line 1: | Line 1: | ||
Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7). Elotuzumab is the first FDA-approved medication in this category. | Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7). Elotuzumab is the first FDA-approved medication in this category. | ||
| + | |||
| + | [[Category:Antibody medications]] | ||
Revision as of 19:40, 19 July 2017
Drugs that have some demonstrated degree of efficacy through the inhibition of Signaling Lymphocytic Activation Molecule Family member 7 (SLAMF7). Elotuzumab is the first FDA-approved medication in this category.
Pages in category "Anti-SLAMF7 antibodies"
This category contains only the following page.